Sarah H. Wild
About
Sarah H. Wild is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Sarah H. Wild has authored 336 papers receiving a total of 30.4k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Endocrinology, Diabetes and Metabolism, 114 papers in Epidemiology and 49 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sarah H. Wild's work include Chronic Disease Management Strategies (60 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (60 papers) and Diabetes Management and Research (53 papers). Sarah H. Wild is often cited by papers focused on Chronic Disease Management Strategies (60 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (60 papers) and Diabetes Management and Research (53 papers). Sarah H. Wild collaborates with scholars based in United Kingdom, South Korea and United States. Sarah H. Wild's co-authors include Gojka Roglić, Anders Green, Richard Sicree, Hilary King, Christopher D. Byrne, Paul McKeigue, Pouya Saeedi, Suvi Karuranga, Howard S. Jacobs and T. Pierpoint and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.
In The Last Decade
Sarah H. Wild
316 papers receiving 28.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sarah H. Wild United Kingdom | 60 | 14.0k | 5.6k | 5.0k | 4.0k | 3.7k | 336 | 30.4k | ||
| William H. Herman United States | 83 | 19.1k 1.4× | 5.2k 0.9× | 7.0k 1.4× | 5.7k 1.4× | 5.1k 1.4× | 411 | 37.0k | ||
| Elizabeth Selvin United States | 86 | 12.1k 0.9× | 4.1k 0.7× | 4.1k 0.8× | 5.5k 1.4× | 4.0k 1.1× | 518 | 33.1k | ||
| Juliana C.N. Chan Hong Kong | 87 | 18.0k 1.3× | 6.3k 1.1× | 7.9k 1.6× | 5.9k 1.5× | 5.1k 1.4× | 849 | 39.5k | ||
| Viswanathan Mohan India | 95 | 17.2k 1.2× | 7.5k 1.3× | 5.8k 1.1× | 5.9k 1.5× | 5.8k 1.6× | 1.2k | 39.8k | ||
| Frederick L. Brancati United States | 86 | 11.7k 0.8× | 7.4k 1.3× | 4.4k 0.9× | 3.5k 0.9× | 3.9k 1.1× | 250 | 30.3k | ||
| Edward J. Boyko United States | 97 | 15.8k 1.1× | 8.6k 1.5× | 4.3k 0.9× | 5.5k 1.4× | 6.8k 1.8× | 458 | 39.8k | ||
| Edward W. Gregg United States | 94 | 18.4k 1.3× | 6.3k 1.1× | 3.9k 0.8× | 4.3k 1.1× | 7.2k 2.0× | 353 | 37.0k | ||
| Stephen Colagiuri Australia | 60 | 10.6k 0.8× | 3.0k 0.5× | 3.5k 0.7× | 3.6k 0.9× | 4.3k 1.2× | 243 | 22.8k | ||
| K.M. Venkat Narayan United States | 79 | 12.6k 0.9× | 5.4k 1.0× | 2.4k 0.5× | 2.5k 0.6× | 3.7k 1.0× | 472 | 27.2k | ||
| Suvi Karuranga Belgium | 16 | 8.9k 0.6× | 3.1k 0.5× | 4.6k 0.9× | 2.8k 0.7× | 3.2k 0.9× | 20 | 21.5k |
Countries citing papers authored by Sarah H. Wild
Since
Specialization
Citations
This map shows the geographic impact of Sarah H. Wild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah H. Wild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah H. Wild more than expected).
Fields of papers citing papers by Sarah H. Wild
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sarah H. Wild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah H. Wild. The network helps show where Sarah H. Wild may publish in the future.
Co-authorship network of co-authors of Sarah H. Wild
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah H. Wild. A scholar is included among the top collaborators of Sarah H. Wild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah H. Wild. Sarah H. Wild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mesa‐Eguiagaray, Ines, Sarah H. Wild, Linda Williams, et al.. (2025). Breast cancer-specific survival by molecular subtype in different age groups of women in Scotland. Breast Cancer Research. 27(1). 59–59.
2.
Blackbourn, Luke A. K., Stuart J. McGurnaghan, Stewart W Mercer, et al.. (2024). Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time‐trend analysis from 2004 to 2021. British Journal of Clinical Pharmacology. 90(11). 2802–2810.
3.
Kim, Yejin, Yoosoo Chang, Seungho Ryu, et al.. (2023). Nonalcoholic fatty liver disease and risk of incident young-onset hypertension: Effect modification by sex. Nutrition Metabolism and Cardiovascular Diseases. 33(8). 1608–1616.
4.
Field, Benjamin C. T., Yue Ruan, Jim Davies, et al.. (2023). A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID ‐19. Diabetes Obesity and Metabolism. 25(7). 2012–2022.
5.
Wild, Sarah H., et al.. (2022). Depression, diabetes, comorbid depression and diabetes and risk of all-cause and cause-specific mortality: a prospective cohort study. Diabetologia. 65(9). 1450–1460.
6.
Butterly, Elaine, Lili Wei, Amanda Adler, et al.. (2022). Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol. BMJ Open. 12(10). e066491–e066491.
7.
Díaz, Lars Jorge, Caroline Jackson, Sarah H. Wild, et al.. (2022). Indicators of quality of diabetes care in persons with type 2 diabetes with and without severe mental illness: a Danish nationwide register-based cohort study. The Lancet Regional Health - Europe. 26. 100565–100565.
8.
McGurnaghan, Stuart J., Luke A. K. Blackbourn, Thomas M. Caparrotta, et al.. (2022). Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland. BMJ Open. 12(10). e063046–e063046.
9.
Sun, Hong, Pouya Saeedi, Suvi Karuranga, et al.. (2021). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice. 183. 109119–109119.
10.
McGurnaghan, Stuart J., Paul McKeigue, Stephanie H. Read, et al.. (2021). Development and validation of a cardiovascular risk prediction model in type 1 diabetes. Diabetologia. 64(9). 2001–2011.
11.
Bavuma, Charlotte, et al.. (2019). Atypical forms of diabetes mellitus in Africans and other non-European ethnic populations in low- and middle-income countries: a systematic literature review. Journal of Global Health. 9(2). 20401–20401.
12.
McGurnaghan, Stuart J., Liam Brierley, Thomas M. Caparrotta, et al.. (2019). The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study. Diabetologia. 62(4). 621–632.
13.
Basu, Sanjay, John Yudkin, Sylvia Kehlenbrink, et al.. (2018). Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis. The Lancet Diabetes & Endocrinology. 7(1). 25–33.
14.
Pearce, Gemma, Hannah L Parke, Eleni Epiphaniou, et al.. (2018). Supported self-management for people with type 2 diabetes: a meta-review of quantitative systematic reviews. BMJ Open. 8(12). e024262–e024262.
15.
Lone, Nazir, Michael Gillies, Catriona Haddow, et al.. (2016). Five-Year Mortality and Hospital Costs Associated with Surviving Intensive Care. American Journal of Respiratory and Critical Care Medicine. 194(2). 198–208.
16.
Carstensen, Bendix, Stephanie H. Read, Søren Friis, et al.. (2016). Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals. Diabetologia. 59(5). 980–988.
17.
Hanley, Janet, Peter Fairbrother, Lucy McCloughan, et al.. (2015). Qualitative study of telemonitoring of blood glucose and blood pressure in type 2 diabetes. BMJ Open. 5(12). e008896–e008896.
18.
McAllister, David, Katherine A. Hughes, Nazir Lone, et al.. (2014). Stress Hyperglycaemia in Hospitalised Patients and Their 3-Year Risk of Diabetes: A Scottish Retrospective Cohort Study. PLoS Medicine. 11(8). e1001708–e1001708.
19.
Bhopal, Raj, Anne Douglas, Sunita Wallia, et al.. (2013). Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. The Lancet Diabetes & Endocrinology. 2(3). 218–227.
20.
Byrne, Christopher D. & Sarah H. Wild. (2011). The metabolic syndrome: science and clinical practice. Wiley-Blackwell eBooks.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by William H. Herman Breakdown of academic impact, for papers by Elizabeth Selvin Breakdown of academic impact, for papers by Juliana C.N. Chan Breakdown of academic impact, for papers by Viswanathan Mohan Breakdown of academic impact, for papers by Frederick L. Brancati Breakdown of academic impact, for papers by Edward J. Boyko Breakdown of academic impact, for papers by Edward W. Gregg Breakdown of academic impact, for papers by Stephen Colagiuri Breakdown of academic impact, for papers by K.M. Venkat Narayan Breakdown of academic impact, for papers by Suvi Karuranga